Competing Interests statement
Rudolf Valenta has received research grants from the Austrian Science Fund (FWF), HVD Biotech, Vienna, Austria, Worg Pharmaceuticals, Hangzhou, China and Viravaxx, Vienna, Austria and serves as a consultant for Viravaxx. The other authors do not have any conflicts of interest.